TruSight Oncology 500 genomic profiling

Source Genomics offers Illumina TruSight Oncology 500 (TSO500) next-generation sequencing as a service for comprehensive genomic profiling of tumour samples.

Talk to us about your requirements today. We are here to help you reach your research goals quickly and efficiently.

Using the TSO500 assay we have the capability to run a single comprehensive NGS assay, greatly increasing the chances of identifying a positive biomarker.

Outsourcing your genomic profiling with Source Genomics provides access to our highly experienced scientists and state-of the art ISO accredited genomics facilities, therefore guaranteeing consistently high-quality results and unrivalled turnaround times across every project.


The benefits of partnering with Source Genomics for your next TSO500 project:

  • Unrivaled turnaround times.
  • Consistent high-quality results across every project.
  • Scientists are qualified and experienced with the TSO500 assay.
  • Europe’s leading provider of commercial sequencing.
  • Sequencing takes place in-house at ISO accredited laboratories, no outsourcing to additional or third-party sites.
  • Free consultation and support throughout each project.

More about the TruSight Oncology 500 Assay

TruSight Oncology 500 enables researchers to characterize tumours and identify the next generation of clinical biomarkers. The assay analyses 523 cancer-relevant genes from both DNA and RNA in one integrated workflow. It assesses multiple variant types in a single assay including small nucleotide variants (SNVs), indels, splice variants, fusions and emerging immunotherapy biomarkers including microsatellite instability (MSI) and tumour mutational burden (TMB).

The TruSight Oncology 500 Assay offers many benefits including:

  • The ability to consolidate multiple biomarker assays into one

Comprehensive coverage of pan-cancer content, aligned with key guidelines spanning 523 cancer-relevant genes for assessment of all DNA and RNA variant types, and MSI and TMB. Moving to a single comprehensive NGS assay from individual biomarker assays increases the chances of finding a positive biomarker.

  • Highly confident results

Enrichment chemistry including UMIs coupled with an informatics pipeline for high accuracy in variant detection.

  • Streamlined workflow

Contact us today and one of our skilled account managers will be in touch with a free consultation including further information and pricing details.

Sanger Sequencing

Established as a market-leading Sanger Sequencing service provider, we deliver rapid turnaround times for sequencing using our streamlined SpeedREAD™ data delivery system, to the highest quality.